Clinical trials recruiting for Pancreatic Cancer, Adult

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• Adebrelimab and Chidamide for Pancreatic Cancer
  NCT06584227 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer
  NCT07529626 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer
  NCT07629609 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer
  NCT06800469 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Neutrophil-to-lymphocyte Ratio and CA 19.9 as Predictors of Perineural Invasion in Pancreatic Cancer
  NCT06747481 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Pancreatic Cancer Detection Consortium
  NCT06388967 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 11 locations
• Pancreatic Cancer Screening for At-risk Individuals
  NCT05006131 · Phase: Not specified · Ages: 18 Years to 90 Years · Sex: All (male and female) · 1 location
• Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
  NCT06822413 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 8 locations
• Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer
  NCT07436741 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Surveillance of Pancreatic Health After Diabetes Diagnosis
  NCT06803771 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 84 Years · Sex: All (male and female) · 31 locations
• The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
  NCT06717295 · Phase: Not specified · Ages: 40 Years to 75 Years · Sex: All (male and female) · 8 locations
• To Evaluate the Preliminary Efficacy of Our Digitally Enhanced CHW-led Intervention in Newly Diagnosed PDAC
  NCT07591571 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Months and older · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Pancreatic Cancer, Adult often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Pancreatic Cancer, Adult trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.